VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
AVTRAvantor, Inc.
$9.58$6.5B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

AVTR logoAvantor, Inc.(AVTR)Earnings, Financials & Key Ratios

AVTR•NYSE
Price updated Jun 19, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDiagnostics and life science tools
AboutAvantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.Show more
  • Revenue$6.55B-3.4%
  • EBITDA$164M-89.0%
  • Net Income-$530M-174.5%
  • EPS (Diluted)-0.78-175.0%
  • Gross Margin32.65%-2.8%
  • EBITDA Margin2.5%-88.6%
  • Operating Margin-3.76%-123.5%
  • Net Margin-8.09%-177.2%
  • ROE-9.2%-172.5%

AVTR Key Insights

Avantor, Inc. (AVTR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Trading at only 1.2x book value

✗Weaknesses

  • ✗Weak 3Y average ROE of 3.3%
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when AVTR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AVTR Price & Volume

Avantor, Inc. (AVTR) stock price & volume — 10-year historical chart

Loading chart...

AVTR Growth Metrics

Avantor, Inc. (AVTR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years0.49%
3 Years-4.46%
TTM-1.99%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-177.05%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-176.67%

Return on Capital

10 Years4.81%
5 Years6.43%
3 Years4.54%
Last Year-2.4%

AVTR Recent Earnings

Avantor, Inc. (AVTR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 7/12 qtrs (58%)●Beat Revenue 7/12 qtrs (58%)
Q2 2026Latest
Apr 29, 2026
Metric
Actual
Est
EPS
$0.17+6.3%
$0.16
Rev
$1.6B+2.5%
$1.5B
Q1 2026
Feb 11, 2026
Metric
Actual
Est
EPS
$0.22+4.8%
$0.21
Rev
$1.7B+1.6%
$1.6B
Q4 2025
Oct 29, 2025
Metric
Actual
Est
EPS
$0.22-2.1%
$0.22
Rev
$1.6B-1.3%
$1.6B
Q3 2025
Aug 1, 2025
Metric
Actual
Est
EPS
$0.24-4.0%
$0.25
Rev
$1.7B+2.3%
$1.6B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 29, 2026
$0.17vs $0.16+6.3%
$1.6Bvs $1.5B+2.5%
Q1 2026Feb 11, 2026
$0.22vs $0.21+4.8%
$1.7Bvs $1.6B+1.6%
Q4 2025Oct 29, 2025
$0.22vs $0.22-2.1%
$1.6Bvs $1.6B-1.3%
Q3 2025Aug 1, 2025
$0.24vs $0.25-4.0%
$1.7Bvs $1.6B+2.3%
Based on last 12 quarters of dataView full earnings history →

AVTR Peer Comparison

Avantor, Inc. (AVTR) competitors in Diagnostics and life science tools — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
TMO logoTMOThermo Fisher Scientific Inc.Direct Competitor172.66B464.6126.193.91%15.18%13.23%0.76
DHR logoDHRDanaher CorporationDirect Competitor125.4B177.1735.152.9%14.89%7.06%0.35
MLAB logoMLABMesa Laboratories, Inc.Direct Competitor525.42M95.1078.603.38%2.69%3.71%0.48
SITE logoSITESiteOne Landscape Supply, Inc.Direct Competitor4.88B110.1732.693.62%3.24%9.09%0.58
WAT logoWATWaters CorporationProduct Competitor23.17B355.4433.036.99%11.91%8.04%0.55
A logoAAgilent Technologies, Inc.Product Competitor35.89B127.0627.806.73%19.55%20.84%0.50
TECH logoTECHBio-Techne CorporationProduct Competitor9.07B57.94125.965.23%9.05%5.49%0.23
IDXX logoIDXXIDEXX Laboratories, Inc.Product Competitor44.64B562.0942.9710.42%24.63%70.87%0.67

Compare AVTR vs Peers

Avantor, Inc. (AVTR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs TMO

Most directly comparable listed peer for AVTR.

Scale Benchmark

vs DHR

Larger-name benchmark to compare AVTR against a more recognizable public peer.

Peer Set

Compare Top 5

vs TMO, DHR, MLAB, SITE

AVTR Income Statement

Avantor, Inc. (AVTR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
1.25B5.86B6.04B6.39B7.39B7.51B6.97B6.78B6.55B6.55B
Revenue Growth %
80.44%370.12%3%5.85%15.52%1.71%-7.26%-2.64%-3.41%-1.99%
Cost of Goods Sold
814.6M4.04B4.12B4.31B4.88B4.91B4.6B4.5B4.41B4.45B
COGS % of Revenue
65.3%68.97%68.2%67.46%66.12%65.35%66.07%66.4%67.35%-
Gross Profit
432.8M▲ 0%
1.82B▲ 320.5%
1.92B▲ 5.5%
2.08B▲ 8.3%
2.5B▲ 20.3%
2.6B▲ 4.0%
2.36B▼ 9.2%
2.28B▼ 3.6%
2.14B▼ 6.1%
2.11B▲ 0%
Gross Margin %
34.7%31.03%31.8%32.54%33.88%34.65%33.93%33.6%32.65%32.13%
Gross Profit Growth %
35.38%320.47%5.54%8.32%20.29%4%-9.18%-3.57%-6.14%-
Operating Expenses
643.2M1.41B1.37B1.37B1.53B1.47B1.67B1.19B2.39B2.38B
OpEx % of Revenue
51.56%23.98%22.66%21.49%20.72%19.6%23.93%17.61%36.41%-
Selling, General & Admin
643.2M1.41B1.37B1.37B1.53B1.47B1.51B1.64B1.6B1.21B
SG&A % of Revenue
51.56%23.98%22.66%21.49%20.72%19.6%21.62%24.19%24.35%-
Research & Development
0000000000
R&D % of Revenue
----------
Other Operating Expenses
000000160.8M-446.6M790.1M3M
Operating Income
-210.4M▲ 0%
413.5M▲ 296.5%
551.8M▲ 33.4%
706.8M▲ 28.1%
972.2M▲ 37.5%
1.13B▲ 16.3%
696.4M▼ 38.4%
1.08B▲ 55.8%
-246.2M▼ 122.7%
-278.6M▲ 0%
Operating Margin %
-16.87%7.05%9.14%11.05%13.16%15.04%10%15.99%-3.76%-4.25%
Operating Income Growth %
-2225.25%296.53%33.45%28.09%37.55%16.25%-38.38%55.77%-122.7%-
EBITDA
-111.2M818.1M950.7M1.1B1.35B1.54B1.1B1.49B164M136.9M
EBITDA Margin %
-8.91%13.95%15.74%17.24%18.3%20.44%15.77%21.97%2.5%2.09%
EBITDA Growth %
-258.4%835.7%16.21%15.94%22.61%13.64%-28.46%35.64%-89%-90.82%
D&A (Non-Cash Add-back)
99.2M404.6M398.9M395.4M379.2M405.5M402.3M405.5M410.2M415.5M
EBIT
-259.3M410M480.6M369.9M970.4M1.12B695.3M1.07B-271.5M-284.4M
Net Interest Income
-200.9M-523.8M-440M-307.6M-217.4M-265.8M-284.8M-218.8M-169.8M-172.4M
Interest Income
00000000010.5M
Interest Expense
200.9M523.8M440M307.6M217.4M265.8M284.8M218.8M169.8M182.9M
Other Income/Expense
-249.8M-527.3M-511.2M-644.5M-219.2M-279.1M-285.9M-230.9M-195.1M-192.9M
Pretax Income
-460.2M▲ 0%
-113.8M▲ 75.3%
40.6M▲ 135.7%
62.3M▲ 53.4%
753M▲ 1108.7%
851.1M▲ 13.0%
410.5M▼ 51.8%
853.9M▲ 108.0%
-441.3M▼ 151.7%
-471.5M▲ 0%
Pretax Margin %
-36.89%-1.94%0.67%0.97%10.19%11.33%5.89%12.59%-6.74%-7.2%
Income Tax
-314.9M-26.9M2.8M-54.3M180.4M164.6M89.4M142.4M88.9M79.9M
Effective Tax Rate %
68.43%23.64%6.9%-87.16%23.96%19.34%21.78%16.68%-20.15%-16.95%
Net Income
-112.7M▲ 0%
-86.9M▲ 22.9%
37.8M▲ 143.5%
116.6M▲ 208.5%
572.6M▲ 391.1%
686.5M▲ 19.9%
321.1M▼ 53.2%
711.5M▲ 121.6%
-530.2M▼ 174.5%
-551.4M▲ 0%
Net Margin %
-9.03%-1.48%0.63%1.82%7.75%9.14%4.61%10.49%-8.09%-8.42%
Net Income Growth %
-165.8%22.89%143.5%208.47%391.08%19.89%-53.23%121.58%-174.52%-177.05%
Net Income (Continuing)
-145.3M-86.9M37.8M116.6M572.6M686.5M321.1M711.5M-530.2M-551.4M
Discontinued Operations
0000000000
Minority Interest
0000000000
EPS (Diluted)
-0.84▲ 0%
-0.72▲ 14.3%
-0.84▼ 16.7%
0.09▲ 110.7%
0.85▲ 844.4%
1.01▲ 18.8%
0.47▼ 53.5%
1.04▲ 121.3%
-0.78▼ 175.0%
-0.81▲ 0%
EPS Growth %
-873.35%14.29%-16.67%110.71%844.44%18.82%-53.47%121.28%-175%-176.67%
EPS (Basic)
-0.84-0.72-0.840.090.861.020.481.05-0.78-
Diluted Shares Outstanding
496.5M496.5M401.2M583.4M599.6M679.4M678.4M681.9M679.3M679.3M
Basic Shares Outstanding
496.5M496.5M401.2M576.3M590.5M650.9M675.6M680.3M678M678M
Dividend Payout Ratio
--82.8%-------

AVTR Balance Sheet

Avantor, Inc. (AVTR) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
1.83B1.9B2.02B2.23B2.48B2.66B2.38B2.15B2.45B2.4B
Cash & Short-Term Investments
185.4M184.7M186.7M286.6M301.7M372.9M262.9M261.9M365.4M279.3M
Cash Only
185.4M184.7M186.7M286.6M301.7M372.9M262.9M261.9M365.4M279.3M
Short-Term Investments
0000000000
Accounts Receivable
875M931.2M988.8M1.11B1.22B1.22B1.15B1.03B1.07B1.1B
Days Sales Outstanding
256.0357.9659.7563.5660.3959.260.2655.6659.8661.37
Inventory
695.1M671.1M711.2M739.6M872M913.5M828.1M731.5M818.2M810.3M
Days Inventory Outstanding
311.4660.5663.0162.5965.1867.9165.6659.2867.6865.74
Other Current Assets
78.3M112.6M134.8M91.4M81.4M153.1M143.7M118.7M193M209.9M
Total Non-Current Assets
8.61B8.01B7.75B7.68B11.42B10.81B10.59B9.97B9.34B9.26B
Property, Plant & Equipment
663.5M598.6M557M549.9M705.5M727M737.5M708.1M766.8M766.2M
Fixed Asset Turnover
1.88x9.80x10.84x11.63x10.47x10.33x9.45x9.58x8.54x8.58x
Goodwill
2.85B2.78B2.77B2.86B5.34B5.65B5.72B5.54B4.99B4.95B
Intangible Assets
4.99B4.57B4.22B4.05B5.14B4.13B3.78B3.36B3.19B3.1B
Long-Term Investments
0000000000
Other Non-Current Assets
112.6M63M205.2M216.7M233.1M293.5M358.3M360.4M396M441.7M
Total Assets
10.45B▲ 0%
9.91B▼ 5.1%
9.77B▼ 1.4%
9.91B▲ 1.4%
13.9B▲ 40.3%
13.46B▼ 3.1%
12.97B▼ 3.7%
12.11B▼ 6.6%
11.79B▼ 2.6%
11.66B▲ 0%
Asset Turnover
0.12x0.59x0.62x0.65x0.53x0.56x0.54x0.56x0.56x0.55x
Asset Growth %
819.75%-5.12%-1.4%1.36%40.28%-3.12%-3.65%-6.62%-2.64%-16.44%
Total Current Liabilities
1.1B1.1B1.07B1.24B1.45B1.66B1.48B2.01B1.38B1.37B
Accounts Payable
542M557.4M560.2M678.9M755.1M758.2M625.9M662.8M741.7M735.5M
Days Payables Outstanding
242.8650.349.6357.4556.4456.3749.6353.7161.3559.05
Short-Term Debt
109M142.4M93.5M26.4M45.2M364.2M259.9M821.1M30.8M37M
Deferred Revenue (Current)
0000000000
Other Current Liabilities
374.3M319.8M346.6M492.9M600.7M486.5M544.3M475M559.1M594.8M
Current Ratio
1.66x1.73x1.88x1.80x1.71x1.60x1.61x1.07x1.78x1.76x
Quick Ratio
1.03x1.12x1.22x1.20x1.11x1.05x1.05x0.70x1.18x1.17x
Cash Conversion Cycle
324.6368.2273.1368.6969.1370.7476.2961.2366.1968.06
Total Non-Current Liabilities
11.96B11.87B6.24B5.99B8.25B6.95B6.24B4.15B4.85B4.71B
Long-Term Debt
7.01B6.78B5.02B4.87B6.98B5.92B5.28B3.23B3.92B0
Capital Lease Obligations
0000000000
Deferred Tax Liabilities
1.05B907.5M785.4M723.9M913M731.4M612.8M557.3M557.1M2.19B
Other Non-Current Liabilities
3.9B4.18B428.2M398.1M358.4M295.4M350.3M358.3M378.2M4.16B
Total Liabilities
13.07B12.96B7.31B7.23B9.7B8.61B7.72B6.16B6.23B6.07B
Total Debt
7.12B6.92B5.12B4.89B7.02B6.29B5.54B4.06B3.95B37M
Net Debt
6.93B6.74B4.93B4.61B6.72B5.91B5.27B3.79B3.58B-242.3M
Debt / Equity
--2.08x1.83x1.67x1.29x1.05x0.68x0.71x0.01x
Debt / EBITDA
-8.46x5.38x4.44x5.20x4.09x5.04x2.72x24.06x0.27x
Net Debt / EBITDA
-8.24x5.19x4.18x4.97x3.85x4.80x2.55x21.83x-1.77x
Interest Coverage
-1.29x0.78x1.09x1.20x4.46x4.20x2.44x4.90x-1.60x-1.55x
Total Equity
-2.62B▲ 0%
-3.05B▼ 16.5%
2.46B▲ 180.7%
2.67B▲ 8.6%
4.2B▲ 56.9%
4.86B▲ 15.7%
5.25B▲ 8.2%
5.96B▲ 13.4%
5.57B▼ 6.6%
5.59B▲ 0%
Equity Growth %
-413.16%-16.47%180.68%8.61%56.94%15.69%8.18%13.4%-6.58%1.03%
Book Value per Share
-5.28-6.156.144.587.007.157.748.748.198.23
Total Shareholders' Equity
-2.62B-3.05B2.46B2.67B4.2B4.86B5.25B5.96B5.57B5.59B
Common Stock
001.75B1.74B2.75B3.79B3.83B3.94B3.98B3.99B
Retained Earnings
-156.3M-238.4M-203.7M-88.7M483.9M1.17B1.49B2.2B1.67B0
Treasury Stock
00000000-75.7M0
Accumulated OCI
26.4M-66.5M-85.9M21.7M-43.2M-100.3M-69M-184M-16.9M-43.7M
Minority Interest
0000000000

AVTR Cash Flow Statement

Avantor, Inc. (AVTR) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-167.5M200.5M354M929.8M953.6M843.6M870M840.8M623.8M573.2M
Operating CF Margin %
-13.43%3.42%5.86%14.54%12.91%11.23%12.49%12.39%9.52%-
Operating CF Growth %
-329.77%219.7%76.56%162.66%2.56%-11.54%3.13%-3.36%-25.81%-118.53%
Net Income
-145.3M-86.9M37.8M116.6M572.6M686.5M321.1M711.5M-530.2M-551.4M
Depreciation & Amortization
99.2M404.6M398.9M395.4M379.2M405.5M402.3M405.5M410.2M415.5M
Stock-Based Compensation
48.2M18.4M67.9M44.1M50.7M45.8M40.5M46.8M46.4M42.6M
Deferred Taxes
-323.6M-139.7M-106.7M-87.5M-17.7M-69.1M-172.4M-46.9M7.7M9.9M
Other Non-Cash Items
81.4M97.9M142.7M441.7M83.3M96.2M261.9M-323.8M888.6M865.3M
Working Capital Changes
72.6M-93.8M-186.6M19.5M-114.5M-321.3M16.6M47.7M-198.9M-208.7M
Change in Receivables
14.1M-83.4M-68.9M-102.4M-111.8M-45.2M77M45.9M13.6M16M
Change in Inventory
19.7M-41.1M-71.1M-69.7M-129.8M-112.5M30.3M-18.5M-109.4M-104M
Change in Payables
31.8M29.4M5.1M110.6M64.9M15.6M-139.6M59.6M42.4M39.6M
Cash from Investing
-6.68B-23.2M-42.1M-59.1M-4.12B-109.6M-143.7M438.9M-130.5M-134.3M
Capital Expenditures
-25.2M-37.7M-51.6M-61.6M-111.1M-133.4M-146.4M-148.8M-128.8M-134.3M
CapEx % of Revenue
2.02%0.64%0.85%0.96%1.5%1.78%2.1%2.19%1.97%2.05%
Acquisitions
-6.66B000-4.01B-20.2M0000
Investments
----------
Other Investing
9.9M14.5M9.5M2.5M3.5M1.5M2.7M587.7M-1.7M0
Cash from Financing
6.96B-170.3M-307.8M-782.9M3.22B-648.7M-843.7M-1.28B-409.4M-483M
Debt Issued (Net)
5.96B-149.8M-1.88B-738.5M2.3B-620.4M-846M-1.34B-318.7M-392.8M
Equity Issued (Net)
3.05B01.6B0941.2M-13.2M-13.7M-8.6M-75.6M-71.4M
Dividends Paid
-1.7B0-31.3M-64.6M-64.6M-32.4M0000
Share Repurchases
00-2.63B-20.2M-25.8M-13.2M-13.7M-8.6M-80.7M-79.4M
Other Financing
-341M-20.5M-3.9M20.2M41.9M17.3M16M69.2M-15.1M-18.8M
Net Change in Cash
122.5M▲ 0%
-800K▼ 100.7%
1.6M▲ 300.0%
99.9M▲ 6143.8%
37.9M▼ 62.1%
69.8M▲ 84.2%
-109.2M▼ 256.4%
-23M▲ 78.9%
103.6M▲ 550.4%
-36.7M▲ 0%
Free Cash Flow
-192.7M▲ 0%
162.8M▲ 184.5%
302.4M▲ 85.7%
868.2M▲ 187.1%
842.5M▼ 3.0%
710.2M▼ 15.7%
723.6M▲ 1.9%
692M▼ 4.4%
495M▼ 28.5%
438.9M▲ 0%
FCF Margin %
-15.45%2.78%5.01%13.58%11.41%9.45%10.39%10.2%7.55%6.7%
FCF Growth %
-548.14%184.48%85.75%187.1%-2.96%-15.7%1.89%-4.37%-28.47%-34.14%
FCF per Share
-0.390.330.751.491.411.051.071.010.730.65
FCF Conversion (FCF/Net Income)
1.49x-2.31x9.37x7.97x1.67x1.23x2.71x1.18x-1.18x-0.80x
Interest Paid
137.2M481.3M405.5M317.8M187M242.2M267M4.2M1.6M57.1M
Taxes Paid
31.5M65.6M112.3M42.7M144.7M256.9M224.4M247.8M145M87.5M

AVTR Key Ratios

Avantor, Inc. (AVTR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)
--1.54%4.54%16.67%15.17%6.35%12.69%-9.2%-9.59%
Return on Invested Capital (ROIC)
-6.27%7.75%7.47%7.23%8.01%7.82%4.91%8.02%-1.95%-2.48%
Gross Margin
34.7%31.03%31.8%32.54%33.88%34.65%33.93%33.6%32.65%32.13%
Net Margin
-9.03%-1.48%0.63%1.82%7.75%9.14%4.61%10.49%-8.09%-8.42%
Debt / Equity
--2.08x1.83x1.67x1.29x1.05x0.68x0.71x0.01x
Interest Coverage
-1.29x0.78x1.09x1.20x4.46x4.20x2.44x4.90x-1.60x-1.55x
FCF Conversion
1.49x-2.31x9.37x7.97x1.67x1.23x2.71x1.18x-1.18x-0.80x
Revenue Growth
80.44%370.12%3%5.85%15.52%1.71%-7.26%-2.64%-3.41%-1.99%
Related:AVTR Dividend History·AVTR Revenue History·AVTR Price History·AVTR P/E History·AVTR Financial Ratios·AVTR Institutional Holders

AVTR SEC Filings & Documents

Avantor, Inc. (AVTR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 29, 2026·SEC

Material company update

Apr 23, 2026·SEC

Material company update

Apr 1, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 11, 2026·SEC

FY 2025

Feb 7, 2025·SEC

FY 2024

Feb 14, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 29, 2026·SEC

FY 2025

Oct 29, 2025·SEC

FY 2025

Aug 1, 2025·SEC

AVTR Frequently Asked Questions

Avantor, Inc. (AVTR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Avantor, Inc. (AVTR) reported $6.55B in revenue for fiscal year 2025. This represents a 848% increase from $691.3M in 2016.

Avantor, Inc. (AVTR) saw revenue decline by 3.4% over the past year.

Avantor, Inc. (AVTR) reported a net loss of $551.4M for fiscal year 2025.

Dividend & Returns

Avantor, Inc. (AVTR) has a return on equity (ROE) of -9.2%. Negative ROE indicates the company is unprofitable.

Avantor, Inc. (AVTR) generated $438.9M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in AVTR back in 2016?

Total return calculator · dividends reinvested · 10+ years of data

See returns →

How much would $100/month in AVTR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →